Cargando…
An NQO1-Initiated and p53-Independent Apoptotic Pathway Determines the Anti-Tumor Effect of Tanshinone IIA against Non-Small Cell Lung Cancer
NQO1 is an emerging and promising therapeutic target in cancer therapy. This study was to determine whether the anti-tumor effect of tanshinone IIA (TSA) is NQO1 dependent and to elucidate the underlying apoptotic cell death pathways. NQO1(+) A549 cells and isogenically matched NQO1 transfected and...
Autores principales: | Liu, Fang, Yu, Guo, Wang, Guangji, Liu, Huiying, Wu, Xiaolan, Wang, Qiong, Liu, Miao, Liao, Ke, Wu, Mengqiu, Cheng, Xuefang, Hao, Haiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407158/ https://www.ncbi.nlm.nih.gov/pubmed/22848731 http://dx.doi.org/10.1371/journal.pone.0042138 |
Ejemplares similares
-
UDP-Glucuronosyltransferase 1A Compromises Intracellular Accumulation and Anti-Cancer Effect of Tanshinone IIA in Human Colon Cancer Cells
por: Liu, Miao, et al.
Publicado: (2013) -
De-novo NAD(+) synthesis regulates SIRT1-FOXO1 apoptotic pathway in response to NQO1 substrates in lung cancer cells
por: Liu, Huiying, et al.
Publicado: (2016) -
Evaluation of Tanshinone IIA Developmental Toxicity in Zebrafish Embryos
por: Wang, Tao, et al.
Publicado: (2017) -
Tanshinone-IIA inhibits myocardial infarct via decreasing of the mitochondrial apoptotic signaling pathway in myocardiocytes
por: Fang, Yeqing, et al.
Publicado: (2021) -
Tanshinone IIA: A Review of its Anticancer Effects
por: Fang, Zhong‐ying, et al.
Publicado: (2021)